What is META's current stock price?

As of now, META is trading at $649.60, with a daily change of -1.67%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

META Stock Analysis & IQ Rating | Meta Platforms

META META Badge

Meta Platforms

$649.60

-$11.02 | -1.67%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$796.25

MKT CAP

$1.64T

52W Low

$479.8

VOL

$8.47M

P/E Ratio

28.75

AVG VOL

$15.61M

RSI

47.30

TREND

Downtrend

BQ Stock IQ

Login to see Meta Platforms (META) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

META Target Price

Login to display

Strengths

META Rewards

Earnings are forecast to grow

META Rewards

Upgraded on attractively valued

META Rewards

Trading below its fair value

META Rewards

Outperform the market

META Price Performance

$650.13 (-0.08%)

$715.26 (-9.18%)

$785.23 (-17.27%)

$676.49 (-3.97%)

1year

6month

3month

1month

META Risk Level

META has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Investors losing confidence

Low

LOW

HIGH

META Analysts Opinion

META overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

META Analysts Opinion

META Analysts opinion is positive and also has improved from the past 3 months

META Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

77%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

47%

68%

META Street Sentiment

META Street Sentiment is extremely bullish and have positive views on the near-term outlook

META Performance Sentiment

Sentiments overview associated with META events and the stock performance.

77%

13%

Positive

Negative

93 out of 121
events present

16 out of 121
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$660.62

Resistance
Price

$589.22

Current Price Range

$667.55

Show methods +

Linked to META

IQ

Close Price

Change

GOOG

4.23

323.01

+2.60%

PINS

3.87

27.56

+1.83%

WB

4.00

10.68

-0.14%

TRIP

3.50

14.52

-1.29%

BIDU

4.27

148.09

+1.34%

META Latest Analysis +

Penguin Solutions Beats Q1 Becomes Less Dependent On Meta: Analyst. ) reiterated a Buy rating and price target of $30.

Today

$651.05 | -1.51%

Rating

Meta Cuts Manus Free From China As Regional Lender Gets Premium Bailout. Meta'.s acquisition of AI startup Manus explicitly excludes Manus'. Chinese operations signaling a trend of Chinese entrepreneurs moving to SingaporeA local government'.s decision to buy Weihai Bank shares at a premium rather than a discount is aimed at maintaining confidence in the lender

AuthorIn the latest edition of China Inc. we examine a massive acquisition by a glob

Today

$651.05 | -1.51%

Activity

Potential

Metas $2 Billion Manus Acquisition Under Chinese Scrutiny For Possible Export Control Violations: Report. The Chinese government is reportedly reviewing META) recent acquisition of AI firm The Chinese Ministry of Commerce is assessing whether Manus’. staff and technology relocation to Singapore followed by the sale to Meta require an export license under Chinese law the Financial Times on Wednesday. The review which is still in its early stages could potentially give Beijing the power to i

Today

$651.05 | -1.51%

Activity

Zymeworks Ziihera Demonstrates Positive Results In Phase 3 Study In Gastroesophageal Adenocarcinoma . (RTTNews) - Zymeworks Inc. (ZYME) a biotechnology company announced positive efficacy and safety results from its Phase 3 HERIZON-GEA-01 trial evaluating Ziihera (zanidatamab-hrii) in HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma.

Today

$651.05 | -1.51%

Activity

Meta Not Among Market Leaders In AI Today Says Brad Gerstner As Altimeter Exits Mark Zuckerberg-Led Company: Report. META) with founder not currently a market leader in artificial intelligence (AI).Check out META’.s stock price here.Speaking on CNBC'.s Halftime Report Gerstner revealed why Meta was conspicuously absent from his top holdings list for 2026.Altimeter originally invested in late 2022 riding the stock’.s surge from roughly $90 a share to over $700 as the company embrace

Today

$651.05 | -1.51%

Activity

Potential

Chinese officials review Metas $2B acquisition of AI startup Manus - FT.

Today

$651.05 | -1.51%

Activity

Meta hires Microsoft exec former Trump deputy as chief legal officer. Meta said Tuesday that it hired former Microsoft legal executive Curtis Joseph Mahoney to become its chief legal officer.

Tue Jan 6, 2026

$660.62 | +0.28%

Activity

Meta Pauses Global Rollout Of $799 Ray-Ban Display Glasses As United States Demand Outstrips Supply . (RTTNews) - Meta (META) has postponed the international launch of its Ray-Ban Display AI glasses citing limited inventories and unexpectedly strong demand in the United States.

Tue Jan 6, 2026

$660.62 | +0.28%

Activity

Meta Pauses Global Launch Of Ray-Ban Smart Glasses After US Rush. META) is delaying its planned international rollout of the Ray-Ban Display as demand in the United States has rapidly outpaced supply forcing the company to rethink its global launch timeline.Meta had initially targeted early 2026 launches in markets including the United Kingdom France Italy and Canada. However strong domestic demand has pushed United States customer waitlists “.”. prompting the company to prioritize fu

Tue Jan 6, 2026

$660.62 | +0.28%

Activity

Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2 Locally Advanced or Metastatic GEA including more than Two Years Median Overall Survival Benefit. VANCOUVER British Columbia Jan. 06 2026 (GLOBE NEWSWIRE) -- . (Nasdaq: ZYME) a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel multifunctional biotherapeutics today announced positive efficacy and safety results from the Phase 3 HERIZON-GEA-0

Tue Jan 6, 2026

$660.62 | +0.28%

Activity

FAQ About META Stock Insights

What is META current stock price?

What are META stock strengths?

What is META Risk Level?

What is META market cap and volume?

What is META current Stock IQ?

Should I buy META stock right now?

Is META a Strong Buy right now?

What does a 'Strong Buy' rating mean for META?

What does a 'Strong Sell' rating mean for META?

What factors influence META's Stock IQ?

Explore our META Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored META Stock Strategies
Effective Risk Management

FIND US ON

Receive our META Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

META META Badge

Meta Platforms

Current Price

$649.60

-$11.02 | -1.67%

52W High

$796.25

MKT CAP

$1.64T

52W Low

$479.8

VOL

$8.47M

P/E Ratio

28.75

AVG VOL

$15.61M

RSI

47.30

TREND

Downtrend

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

META Rewards

Earnings are forecast to grow

META Rewards

Upgraded on attractively valued

META Rewards

Trading below its fair value

META Rewards

Outperform the market

Linked to META

Symbol

IQ

Close

Change

GOOG

4.23

323.01

+2.60%

PINS

3.87

27.56

+1.83%

WB

4.00

10.68

-0.14%

TRIP

3.50

14.52

-1.29%

BIDU

4.27

148.09

+1.34%

META Price Performance

$650.13 (-0.08%)

$715.26 (-9.18%)

$785.23 (-17.27%)

$676.49 (-3.97%)

1year

6month

3month

1month

META Analysts Opinion

META Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

META Analysts Opinion

META Analysts opinion is positive and also has improved from the past 3 months

META Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

77%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

47%

68%

META Street Sentiment

META Street Sentiment is extremely bullish and have positive views on the near-term outlook

META Risk Level

META has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Investors losing confidence

Low

LOW

HIGH

META Performance Sentiment

Sentiments overview associated with META events and the stock performance.

77%

13%

Positive

Negative

93 out of 121
events present

16 out of 121
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$660.62

Resistance
Price

$589.22

Current Price Range

$667.55

Show methods +

META Stock IQ

Login to unlock Meta Platforms (META) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

META Latest Analysis

Penguin Solutions Beats Q1 Becomes Less Dependent On Meta: Analyst. ) reiterated a Buy rating and price target of $30.

Today

$651.05 | -1.51%

Rating

Meta Cuts Manus Free From China As Regional Lender Gets Premium Bailout. Meta'.s acquisition of AI startup Manus explicitly excludes Manus'. Chinese operations signaling a trend of Chinese entrepreneurs moving to SingaporeA local government'.s decision to buy Weihai Bank shares at a premium rather than a discount is aimed at maintaining confidence in the lender

AuthorIn the latest edition of China Inc. we examine a massive acquisition by a glob

Today

$651.05 | -1.51%

Activity

Potential

Metas $2 Billion Manus Acquisition Under Chinese Scrutiny For Possible Export Control Violations: Report. The Chinese government is reportedly reviewing META) recent acquisition of AI firm The Chinese Ministry of Commerce is assessing whether Manus’. staff and technology relocation to Singapore followed by the sale to Meta require an export license under Chinese law the Financial Times on Wednesday. The review which is still in its early stages could potentially give Beijing the power to i

Today

$651.05 | -1.51%

Activity

Zymeworks Ziihera Demonstrates Positive Results In Phase 3 Study In Gastroesophageal Adenocarcinoma . (RTTNews) - Zymeworks Inc. (ZYME) a biotechnology company announced positive efficacy and safety results from its Phase 3 HERIZON-GEA-01 trial evaluating Ziihera (zanidatamab-hrii) in HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma.

Today

$651.05 | -1.51%

Activity

Meta Not Among Market Leaders In AI Today Says Brad Gerstner As Altimeter Exits Mark Zuckerberg-Led Company: Report. META) with founder not currently a market leader in artificial intelligence (AI).Check out META’.s stock price here.Speaking on CNBC'.s Halftime Report Gerstner revealed why Meta was conspicuously absent from his top holdings list for 2026.Altimeter originally invested in late 2022 riding the stock’.s surge from roughly $90 a share to over $700 as the company embrace

Today

$651.05 | -1.51%

Activity

Potential

Chinese officials review Metas $2B acquisition of AI startup Manus - FT.

Today

$651.05 | -1.51%

Activity

Meta hires Microsoft exec former Trump deputy as chief legal officer. Meta said Tuesday that it hired former Microsoft legal executive Curtis Joseph Mahoney to become its chief legal officer.

Tue Jan 6, 2026

$660.62 | +0.28%

Activity

Meta Pauses Global Rollout Of $799 Ray-Ban Display Glasses As United States Demand Outstrips Supply . (RTTNews) - Meta (META) has postponed the international launch of its Ray-Ban Display AI glasses citing limited inventories and unexpectedly strong demand in the United States.

Tue Jan 6, 2026

$660.62 | +0.28%

Activity

Meta Pauses Global Launch Of Ray-Ban Smart Glasses After US Rush. META) is delaying its planned international rollout of the Ray-Ban Display as demand in the United States has rapidly outpaced supply forcing the company to rethink its global launch timeline.Meta had initially targeted early 2026 launches in markets including the United Kingdom France Italy and Canada. However strong domestic demand has pushed United States customer waitlists “.”. prompting the company to prioritize fu

Tue Jan 6, 2026

$660.62 | +0.28%

Activity

Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2 Locally Advanced or Metastatic GEA including more than Two Years Median Overall Survival Benefit. VANCOUVER British Columbia Jan. 06 2026 (GLOBE NEWSWIRE) -- . (Nasdaq: ZYME) a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel multifunctional biotherapeutics today announced positive efficacy and safety results from the Phase 3 HERIZON-GEA-0

Tue Jan 6, 2026

$660.62 | +0.28%

Activity

Discover META Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of META. We're here to help you make informed investment decisions today.

FIND US ON

Receive our META Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

META Stock trends

META Stock performance

META Stock analysis

META investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing META

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing META

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

META Stock Analysis & IQ Rating | Meta Platforms

BQ Stock IQ

META Target Price

META Risk Level

META Analysts Opinion

META Street Sentiment

META Performance Sentiment

Technical Price Levels

Explore our META Stock insights

Receive our META Daily Alerts

META Street Sentiment

META Risk Level

Technical Price Levels

Discover META Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of META. We're here to help you make informed investment decisions today.

Receive our META Daily Alerts

META Alerts